Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 3,320,645 | 2,433,061 | 2,948,963 | 2,760,064 | 6,871,001 | 18,333,734 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 3,320,645 | 2,433,061 | 2,948,963 | 2,760,064 | 6,871,001 | 18,333,734 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 5,031,871 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 13,301,863 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 3,320,645 | 2,433,061 | 2,948,963 | 2,760,064 | 6,871,001 | 18,333,734 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 89,183 | 77,059 | 55,143 | 59,818 | 84,872 | 366,075 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 155,863 | 36,329 | 192,192 | |||
| 11 | Total support. Add lines 7 through 10 | 18,892,001 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990 PART VI SECTION B LINE 11B | The Finance and Audit Committee reviews the 990 for approval. After THEY HAVE APPROVED the 990, A COPY IS distributed to all members of the Board before it is filed. |
| FORM 990 PART VI SECTION B LINE 12C | THE FINANCE AND AUDIT COMMITTEE MANAGES THE COMPLIANCE WITH THE CONFLICTS OF INTEREST POLICY THROUGHOUT THE YEAR. |
| FORM 990 PART VI SECTION C LINE 19 | Avaliable upon request. |
| FORM 990 PART VI SECTION B LINE 15 | THE SALARY OF THE PRESIDENT & CEO IS REVIEWED EVERY SECOND YEAR. A REVIEW WAS CARRIED OUT IN FISCAL YEAR ending 2022. THE REVIEW INCLUDED THE HR AND THE ACCOUNTING CONSULTANTS ANALYZING VARIOUS SALARY SURVEYS AS WELL AS SALARIES OF SIMILAR ORGANIZATIONS. THE ACCOUNTING CONSULTANT DISCUSSED THE DATA ANALYSIS WITH THE EXECUTIVE COMMITTEE. THE EXECUTIVE COMMITTEE THEN SEt THE NEW SALARY OF THE PRESIDENT & CEO. |
| FORM 990, PART III, LINE 4A | Education, Research and Training Twenty-five fellows were selected to participate in the Leadership Training Academy (LTA) Fellowship Class of 2023, chosen from 85 applicants-our largest candidate pool to date. The Class of 2023includes physicians from 18 states and 4 medical specialties. This year we moved to a hybrid model, where one in-depth training was held virtually and one was in person, in Washington, DC. In both trainings, the group participated in sessions focused on media skills, professional leadership and policy advocacy including an advocacy day with staff from congressional offices. Additionally, the class attended six webinars, and the faculty and topics for these were as follows: . Dr. Kristyn Brandi, "Provider Contraceptive Coercion" . Drs. Glenna Martin & Anuj Khattar, "Substance Use Disorder and Reproductive Health" . Dr. Ghazaleh Moayedi and Sara Ainsworth, If/When/How, "Self-Managed Abortion" . Drs. Tracey Wilkinson and Tiffany Hailstorks, " Utilizing Your Reproductive Health Research for Advocacy" . Dr. Jamila Perritt and Maria Ramos of Interrupting Criminalization on, "Decriminalizing Pregnancy & Abortion" This year we launched an official Alumni Program to foster community, offer updated advocacy skills training, and promote continued engagement between LTA Alumni, PRH staff and our community partners. We created a full-time LTA Alumni Program Director position, as well as an LTA Program Manager position, to lead our efforts with each current class of fellows. We held a virtual convening for LTA Alumni which included regional breakout discussions for the doctors in each region to support each other and share strategies for navigating the immediate Post-Dobbs environment. We also held in -person Alumni networking sessions at the National Abortion Federation and American College of Ob/Gyns Annual Meetings. |
| FORM 990, PART III, LINE 4B | Public Policy and Community Support Over the past year, our physician-advocates and staff continued to serve as trusted authorities and impact a range of reproductive health discussions and dialogues in the public arena. We continue to be in close relationships with federal and state coalition partners, working to effectively advocate for expanded protections for abortion and speaking out against harmful restrictions. This has become critically important in the fall out from the Supreme Court's Dobbs decision and the onslaught of attacks on mifepristone. Specific highlights include: . PRH staff and members of the PRH network met regularly with policymakers lending expertise on a variety of reproductive health issues. - Thirty-four physicians met virtually with federal legislative offices and their staffs in September 2023 to discuss access to abortion and access to care for immigrant families. The group also met jointly with dozens of leadership staff from the Pro-Choice Caucus. - Our 2023 Leadership Training Academy class met with two dozen legislative offices on Capitol Hill in March 2023 to discuss access to abortion care. - PRH staff and network members briefed members of Congress and their staffs on many issues related to abortion access, LGBTQ+ issues, immigrant access to care, and maternal health. - Several PRH physicians briefed Biden Administration staff, White House staff, and Vice President Harris including PRH President & CEO Dr. Jamila Perritt and PRH Board Chair Dr. Kristyn Brandi. . PRH physicians testified before Congress. - In July 2022, PRH Board Member Dr. Ghazaleh Moayedi and PRH Fellow Dr. Jacquelyn Lamme testified before the House Armed Services Committee. In October 2022, PRH Board Member Dr. Bhavik Kumar and PRH Fellow Dr. Nisha Verma testified before the House Oversight Committee. - In April 2023, PRH Fellow Dr. Nisha Verma testified before the Senate Judiciary Committee about the coordinated attacks on reproductive health care. . PRH continued our blog series about public policy issues and reproductive health focusing on topics including medication abortion, Black maternal health, harassment of abortion providers and patients, abortion access, and contraception. . PRH submitted amicus briefs to the Fifth Circuit Court of Appeals and the United States Supreme Court in Alliance for Hippocratic Medicine's challenge to the 2000 FDA approval of mifepristone for medication abortion. The briefs discuss the proven safety and efficacy of mifepristone and why it is critical that the medication remain accessible in the United States. |
| FORM 990, PART III, LINE 4C | Voice and Engagement/COMMMUNICATIONS After a year of continued onslaughts on abortion access and gender affirming care from state legislatures in addition to whiplash in the courts with cases threatening access to mifepristone, our physician advocates have been even more active and engaged. As dedicated advocates for the communities in which they live and work, our physicians continue to provide an insider's perspective on reproductive health care and explain clearly how restrictions on any aspect of reproductive health care impact their ability to provide evidence-based care to patients. They offered front line and expert perspectives on the ripple effect of abortion bans on the overall health and wellbeing of communities including on access to contraception, maternal health, ability to care for pregnant people and their needs, and infant health. Through congressional testimony, reporter roundtables, media appearances in print and online, on the radio, and on television, and speaking out on their personal social media platforms, there were countless opportunities to demonstrate the harm caused by health care restrictions on state and national levels. In the 2023 fiscal year from July 2022 to June 2023, the PRH Twitter account lifted up the expertise of our physician advocates with over 2.4m impressions. Our Instagram account garnered over 4.6m impressions. We continue to use our social media presence to educate the public about reproductive health, new research, and lift the voices of our community of physician advocates. PRH.org had over 88k unique users with over 100k sessions. Our most visited page beside our homepage was our Press Releases page with 20k views and our Title X Explainer page with 4.7k views. . Our doctors spoke out against the harms of the Dobbs v Jackson Women's Health Organization decision appearing on MSNBC, CNN, NPR, NBC, CBC, and PBS. . Our physician advocates regularly engaged with their state and local reporters to discuss the on the ground implications of fast-moving abortion bans and what they have meant for their community's wellbeing. Speaking to implications on maternal health, the inability to clearly act in emergent situations due to legal complications, the safety of mifepristone and self-managed abortion, and the further worsening of the provider shortage in certain geographic regions, PRH's advocates are the experts in the acute and long-term impacts of bans. . Our doctors educated reporters in roundtables leading up to the first anniversary of Roe v Wade since the Dobbs decision and how abortion bans impact patients and providers on the ground. |
| Form 990, Part I, Line 1 | Organization Mission Statement- To organize, mobilize, and amplify the voices of medical providers to advance sexual and reproductive health, rights, and justice. Our programs combine education, advocacy, and strategic communications to ensure access to abortion care and equitable, comprehensive health care. We believe that this work is necessary for all people to live freely, with dignity, safety, and security. |
| Form 990, Schedule B, Part 1 | Addresses for some donors have been omitted to protect their personal information. |
| FORM 990 PART IX LINE 11G | DESCRIPTION:OTHER PROFESSIONAL FEES TOTAL FEES:289833 |
| FORM 990 PART IX LINE 11G | DESCRIPTION:PROGRAM CONSULTANTS TOTAL FEES:161016 |
| Software ID: | |
| Software Version: |